Frontiers in Molecular Neuroscience (Sep 2023)

A juvenile mouse model of anti-N-methyl-D-aspartate receptor encephalitis by active immunization

  • Shuyu He,
  • Shuyu He,
  • Shuyu He,
  • Chongyang Sun,
  • Chongyang Sun,
  • Qian Zhu,
  • Qian Zhu,
  • Lin Li,
  • Jianyu Huang,
  • Ge Wu,
  • Ge Wu,
  • Yi Cao,
  • Jianxiang Liao,
  • Yi Lu,
  • Qiru Su,
  • Sufang Lin,
  • Xiaopeng Ma,
  • Cheng Zhong

DOI
https://doi.org/10.3389/fnmol.2023.1211119
Journal volume & issue
Vol. 16

Abstract

Read online

IntroductionAnti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a common autoimmune encephalitis, and it is associated with psychosis, dyskinesia, and seizures. Anti-NMDAR encephalitis (NMDARE) in juveniles and adults presents different clinical charactreistics. However, the pathogenesis of juvenile anti-NMDAR encephalitis remains unclear, partly because of a lack of suitable animal models.MethodsWe developed a model of juvenile anti-NMDAR encephalitis using active immunization with an amino terminal domain peptide from the GluN1 subunit (GluN1356 − 385) against NMDARs in 3-week-old female C57BL/6J mice.ResultsImmunofluorescence staining suggested that autoantibody levels in the hippocampus increased, and HEK-293T cells staining identified the target of the autoantibodies as GluN1, suggesting that GluN1-specific immunoglobulin G was successfully induced. Behavior assessment showed that the mice suffered significant cognition impairment and sociability reduction, which is similar to what is observed in patients affected by anti-NMDAR encephalitis. The mice also exhibited impaired long-term potentiation in hippocampal CA1. Pilocarpine-induced epilepsy was more severe and had a longer duration, while no spontaneous seizures were observed.ConclusionThe juvenile mouse model for anti-NMDAR encephalitis is of great importance to investigate the pathological mechanism and therapeutic strategies for the disease, and could accelerate the study of autoimmune encephalitis.

Keywords